Personal profile

Personal webpage

Biography

Prof. Dr. Jürgen Kuball is Chair of the Department of Hematology, and Director of the Bone Marrow Transplantation Program at the UMC Utrecht Cancer Centre. His research activities focus on tumor immunology and the ATMP development of a next generation of engineered immune cells, with an emphasis on the therapeutic potential of individual receptors derived from γδT cells.  His clinical activities focus around acute leukemia and allogeneic stem cell transplantation. He is an active member of European Society for Blood and Marrow Transplantation (EBMT),  and has chaired the Legal Regulatory Affairs Committee of the EBMT since 2019.

 

Dr. Kuball received his medical degree in Hematology at the University of Mainz, Germany, and completed his post-doctoral fellowship at the Fred Hutchinson Cancer Center in Seattle, WA, USA. He joined the Department of Hematology at the UMC Utrecht in 2007 as a hematologist and immunologist. In 2010, he became a VIDI-laureate, and the chair of the Applied & Tumor-Immunology section within the Laboratory of Translation Immunology. He has chaired the Department of Hematology (adults) since 2013.

For more information on experimental and translational research please visit Kuball Laboratories

Fellowship & awards

American Association of Cancer Research-GlaxoSmithKline Scholar in Cancer Research Award (2001)
Stipendiat der Deutschen Krebshilfe (2005-2007)
Team Science recognition award of the „Society for Immunotherapy of Cancer“ to Jürgen Kuball and the University of Washington, USA (2010)
VIDI-Laureate ZonMW, The Netherlands (2010)

External positions

aandeelhouder - shareholder via Gadeta Founders - Century Therapeutics & Adeta

1 Jan 202431 Dec 3999

Chair - Chairing - Immunology Community Life Science

1 Jan 202331 Dec 3999

Secretary team member - bestuurslid - GoCART Coalition (EBMT/EHA)

1 Jan 202331 Dec 3999

Inkomsten licentie - Onderzoek - UMCU Holding

1 Jan 202231 Dec 3999

Commissie lid PPS commissie - grant indieningen voor KWF beoordelen - KWF

1 Jan 202231 Dec 3999

aandeelhouder - Receiving revenues from licensed patents via UMCU - UMC Holding

1 Jan 202131 Dec 3999

Chair legal and rgulatory affairs committee - Chair - EBMT

1 Jan 201931 Dec 3999

grant - grant ontvangen voor onderzoek - Novartis

1 Jan 201531 Dec 3999

Onderzoeker - grant ontvangen voor onderzoek - Miltenyi

1 Jan 201531 Dec 3999

bestuurslid - member general Board - HOVON

1 Jan 201431 Dec 3999

Patent holder multipe inventions licensed to Gadeta-follow up company Century Therapeuitcs &Miltenyi - Patent houder - Various

1 Jan 201331 Dec 3999

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or